Kimelman & Baird, LLC
- SEC CIK
- 0001318103
- Latest filing
- Aug 18, 2026
NVS holding history
Novartis AG in every 13F filed by Kimelman & Baird, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 6,850
- Value
- $1.07M
- % of portfolio
- 0.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,850 | $1.07M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 6,850 | $1.05M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 6,850 | $944.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 6,850 | $878.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 6,850 | $828.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 6,850 | $763.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 6,850 | $666.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 6,850 | $787.9K | 0.1% | −50−0.7% | Reduced | Holders |
| Q2 2024 | 6,900 | $734.6K | 0.1% | – | No prior filing | Holders |